Tissue Total RNA, Colon: rectosigmoid from OriGene Technologies

Product Specs
ItemTissue Total RNA, Colon: rectosigmoid
CompanyOriGene Technologies
Price $370.00Supplier Page View Company Product Page
Catalog NumberCR560279
Quantity5 µg
DiseaseNormal
TissueColon
RNA TypeTotal RNA
TypeTotal RNA

Add to Compare List

OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

Company Profile

Website: http://www.origene.com

(1) Building simplified cancer subtyping and prediction models with glycan gene signaturesCell Reports MethodsAugust 18, 2025Jing Kai, Luyao Yang, Ayman F. AbuElela, Alyaa M. Abdel-Haleem, Asma S. AlAmoodi, Abdulghani A. Bin Nafisah, Alfadel Alshaibani, Ali S. Alzahrani, Vincenzo Lagani, David Gomez-Cabrero, et al.tissue, COAD_T3",Origene Technologies,CR560965 "Colorectal cancer tissue, COAD_T4",Origene Technologies,CR560964 "Colorectal cancer tissue, COAD_T5",Origene Technologies,CR560590 "Healthy colorectal tissue, COAD_N1",Origene

(2) The integrative genomic and functional immunological analyses of colorectal cancer initiating cells to modulate stemness properties and the susceptibility to immune responsesJ Transl MedFebruary 17, 2025Issam Tout, Salim Bougarn, Mohammed Toufiq, Neha Gopinath, Ola Hussein, Abbirami Sathappan, Evonne Chin-Smith, Fazulur Rehaman, Rebecca Mathew, Lisa Mathew, et al.performed to assess miRNA expression in CRC (N = 2; CR561147, CR561162) and normal (N = 2; CR559319, CR559504) tissue pairs (Origene). The target genes for the selected miRNAs have been predicted using BRB ArrayTool

Be the First to Write a Review!